Stent implantation, but not pathogen burden, is associated with plasma C-reactive protein and interleukin-6 levels after percutaneous coronary intervention in patients with stable angina pectoris
- 31 May 2005
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 149 (5) , 876-882
- https://doi.org/10.1016/j.ahj.2004.07.039
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Comparison of effects of a thrombin-based femoral artery closure device with those of a mechanical compression device on serum C-reactive protein and amyloid A after percutaneous coronary interventionThe American Journal of Cardiology, 2003
- Cytokine response after percutaneous coronary intervention in stable angina: Effect of selective glycoprotein IIb/IIIa receptor antagonismAmerican Heart Journal, 2003
- Immunosuppressive therapy for the prevention of restenosis after coronary artery stent implantation (IMPRESS study)Journal of the American College of Cardiology, 2002
- A Prospective Study of Helicobacter pylori Seropositivity and the Risk for Future Myocardial Infarction among Socioeconomically Similar U.S. MenAnnals of Internal Medicine, 2001
- Cytomegalovirus Infection With Interleukin-6 Response Predicts Cardiac Mortality in Patients With Coronary Artery DiseaseCirculation, 2001
- Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis Commentary: Adjustment for potential confounders may have been taken too farBMJ, 2000
- Plasma levels of C-reactive protein after coronary stent implantationEuropean Heart Journal, 2000
- Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosisHeart, 2000
- Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable anginaThe American Journal of Cardiology, 1998
- Coronary Angioplasty Induces a Systemic Inflammatory ResponseThe American Journal of Cardiology, 1997